Business Times DC
SEE OTHER BRANDS

The latest business and economy news from Washington, D.C.

Sonoco Reports Third Quarter 2025 Results

HARTSVILLE, S.C., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today reported financial results for the third quarter ended September 28, 2025.

Summary:

  • Entered into an agreement on September 7, 2025, to sell Sonoco’s ThermoSafe business unit, which is one of the leading providers of temperature-assured packaging, to Arsenal Capital Partners for a total purchase price of up to $725 million, with net proceeds expected to be used to repay existing debt
  • Grew third quarter net sales to $2.1 billion, up 57.3% from the prior-year quarter, primarily from acquisitions
  • Reported third quarter GAAP net income attributable to Sonoco of $122.9 million, up from $50.9 million in the same period in 2024, and diluted earnings per share (“EPS”) attributable to Sonoco of $1.23
  • Improved quarterly adjusted net income attributable to Sonoco by 29.3% year over year to $191.2 million, and reported adjusted diluted earnings per share of $1.92
  • Achieved third quarter adjusted EBITDA of $386 million, up 37.3% from the prior-year quarter
  • Generated $292 million and $277 million of operating cash flow in the third quarter and year-to-date, respectively
  • Adjusted full-year adjusted diluted EPS guidance to between $5.65 and $5.75 from previous guidance of approximately $6.00. Full-year adjusted EBITDA is expected to be between $1.30 billion and $1.35 billion, substantially in line with previous guidance of $1.30 billion and $1.40 billion. Cash flows from operating activities are expected to be between $700 million to $750 million from previous guidance of approximately $800 million.

*Note: References in today’s news release to consolidated “net sales,” “operating profit,” and “adjusted operating profit,” and Consumer Packaging “segment operating profit” and “segment adjusted EBITDA,” along with the corresponding year-over-year comparable results, do not include results of the Company’s Thermoformed and Flexibles Packaging and global Trident businesses (“TFP”), which was sold in April 2025 and is being accounted for as discontinued operations in periods prior to the sale.

Third Quarter2025Consolidated Results
(Dollars in millions except per share data)
             
  Three Months Ended   Nine Months Ended
GAAP Results September 28, 2025 September 29, 2024 Change   September 28, 2025 September 29, 2024 Change
Net sales1 $ 2,131 $ 1,355 57 %   $ 5,751 $ 3,942 46 %
Net sales related to discontinued operations     321 (100 )%     321   995 (68 )%
Operating profit1   195   102 91 %     497   270 84 %
Operating profit related to discontinued operations     26 (100 )%     664   110 501 %
Net income attributable to Sonoco   123   51 141 %     671   207 224 %
EPS (diluted)   1.23   0.51 141 %     6.74   2.09 222 %
               
               
  Three Months Ended   Nine Months Ended
Non-GAAP Results2 September 28, 2025 September 29, 2024 Change   September 28, 2025 September 29, 2024 Change
Adjusted operating profit1 $ 308 $ 174 78 %   $ 768 $ 446 72 %
Adjusted EBITDA   386   281 37 %     1,052   788 33 %
Adjusted net income attributable to Sonoco   191   148 29 %     464   386 20 %
Adjusted EPS (diluted)   1.92   1.49 29 %     4.66   3.89 20 %
               
1Excludes results of discontinued operations.
2See the Company’s definitions of non-GAAP financial measures, explanations as to why they are used, and reconciliations to the most directly comparable U.S. generally accepted accounting principles (“GAAP”) financial measures later in this release.
 
  • Third quarter net sales of $2.1 billion reflect an increase of 57.3% compared to the corresponding prior-year quarter, driven by sales added from our Metal Packaging Europe, Middle East and Africa (“EMEA”) business following the December 4, 2024 acquisition of Titan Holdings I B.V. (“Eviosys”). Additionally, sales benefited from price increases implemented to offset the effects of inflation and tariffs and from the favorable impact of foreign exchange rates.

  • GAAP operating profit for the third quarter increased to $195 million due to operating profit from our Metal Packaging EMEA business following the acquisition of Eviosys, a positive price/cost environment, solid productivity from certain procurement savings, production efficiencies, and fixed cost reduction initiatives, and the absence of losses on the sale of two production facilities in China. These positive factors were partially offset by a negative product mix in certain businesses and higher restructuring costs.

  • Effective tax rates on GAAP income from continuing operations before income taxes and adjusted income from continuing operations before income taxes, were 6.0% and 22.9%, respectively, in the third quarter, compared to 35.2% and 21.1%, respectively, in the same period in 2024.

“I’m incredibly proud of our team’s strong operating performance in the third quarter as we achieved record top-line and bottom-line performance along with margin expansion despite challenging market conditions and higher than expected interest costs, said Howard Coker, President and Chief Executive Officer. “Our Consumer Packaging segment sales and operating profit each grew 117% and adjusted EBITDA increased by 112%. Most of the improvement came from the addition of Metal Packaging EMEA and improved results from our Metal Packaging U.S. business. Our Industrial Paper Packaging segment improved operating profit by 28%, adjusted EBITDA by 21%, operating profit margin by approximately 336 basis points and adjusted EBITDA margin by approximately 359 basis points driven by year-over-year improvement in price/cost and productivity.”

“In addition, we believe the recently announced sale of our ThermoSafe unit will substantially complete Sonoco’s transformation from a large portfolio of diversified businesses into a simplified structure with two core global business segments — Consumer Packaging and Industrial Paper Packaging. Proceeds from the sale, which is expected to close before year-end, are projected to further reduce Sonoco’s net leverage ratio.”

Paul Joachimczyk, Sonoco’s Chief Financial Officer, added, “We generated $292 million in operating cash flow in the quarter which was up 80% over the prior year period due to solid improvement in working capital. We expect further strong cash flow generation in the fourth quarter as the seasonal build of working capital reverses.”

Third Quarter 2025 Segment Results
(Dollars in millions except per share data)

Sonoco reports its financial results in two reportable segments: Consumer Packaging (“Consumer”) and Industrial Paper Packaging (“Industrial”), with all remaining businesses reported as All Other.

  Three Months Ended   Nine Months Ended
Consumer September 28, 2025   September 29, 2024 Change   September 28, 2025   September 29, 2024 Change
                   
Net sales1 $ 1,438     $ 662   117 %   $ 3,732     $ 1,827   104 %
Segment operating profit1 $ 209     $ 96   117 %   $ 510     $ 229   123 %
Segment operating profit margin1   15 %     15 %       14 %     13 %  
Segment Adjusted EBITDA1, 2 $ 260     $ 122   112 %   $ 663     $ 305   117 %
Segment Adjusted EBITDA margin1, 2   18 %     18 %       18 %     17 %  
                                   
  • Consumer segment net sales grew 117%, driven by sales attributable to Metal Packaging EMEA following the acquisition of Eviosys, price increases implemented to offset the effects of inflation and tariffs, and the favorable impact of foreign exchange rates. These increases were partially offset by softer volumes in the rigid paper and U.S. metal packaging businesses.
  • Segment operating profit and segment adjusted EBITDA grew primarily as a result of profits from Metal Packaging EMEA and a strong price/cost environment in our U.S. metal packaging business.

  Three Months Ended   Nine Months Ended
Industrial September 28, 2025   September 29, 2024 Change   September 28, 2025   September 29, 2024 Change
                   
Net sales $ 585     $ 585   %   $ 1,731     $ 1,779   (3 )%
Segment operating profit $ 90     $ 70   28 %   $ 242     $ 203   19 %
Segment operating profit margin   15 %     12 %       14 %     11 %  
Segment Adjusted EBITDA2 $ 123     $ 102   21 %   $ 337     $ 295   14 %
Segment Adjusted EBITDA margin2   21 %     17 %       19 %     17 %  
                                   
  • Industrial segment net sales remained flat at $585 million as volume declines across the segment and the loss of net sales related to the 2024 divestiture of two production facilities in China offset year-over-year price increases.
  • Segment operating profit margin increased to 15% and adjusted EBITDA margin increased to 21% due to price recovery and productivity from certain procurement savings, production efficiencies, and fixed cost reduction initiatives, which were only partially offset by lower volume/mix.

  Three Months Ended   Nine Months Ended  
All Other September 28, 2025   September 29, 2024 Change   September 28, 2025   September 29, 2024 Change  
                     
Net sales $ 108     $ 107   1 %   $ 288     $ 336   (14 )%
Operating profit $ 18     $ 17   5 %   $ 43     $ 48   (11 )%
Operating profit margin   17 %     16 %       15 %     14 %    
Adjusted EBITDA2 $ 21     $ 20   2 %   $ 51     $ 58   (12 )%
Adjusted EBITDA margin2   19 %     19 %       18 %     17 %    
                                     
  • Net sales were relatively flat as volume gains in temperature-assured packaging were essentially offset by lower volume from industrial plastics.
  • Operating profit and adjusted EBITDA improved 5% and 2%, respectively, year over year as solid productivity from certain procurement savings, production efficiencies, and fixed cost reduction initiatives offset lower volumes from industrial plastics and negative price/cost.

1Excludes results of discontinued operations.
2Segment and All Other adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. See the Company’s reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures later in this release.

Balance Sheet and Cash Flow Highlights

  • Cash and cash equivalents, including discontinued operations, were $245 million as of September 28, 2025, compared to $443 million as of December 31, 2024, with the decrease primarily related to changes in net working capital and net debt reduction.
  • Total debt, including discontinued operations, and net debt were $5.2 billion and $4.9 billion, respectively, as of September 28, 2025, reflecting decreases of $1.9 billion and $1.7 billion, respectively, compared to December 31, 2024, primarily related to the repayment of the outstanding $1.5 billion principal amount of borrowings under the Company’s 364-day term loan facility in 2025 using proceeds from the sale of TFP.
  • On September 28, 2025, the Company had available liquidity of $1,405 million, comprising available borrowing capacity under its revolving credit facility of $1,160 million and cash on hand.
  • Cash flow from operating activities for the nine months ended September 28, 2025 was an inflow of $277 million, compared to an inflow of $438 million in the same period of 2024. The main driver of the year-over-year change in operating cash flow was the increased seasonal need for working capital during the year related to Metal Packaging EMEA. This working capital build is expected to reverse during the fourth quarter.
  • Capital expenditures, net of proceeds from sales of fixed assets, for the first nine months of 2025 were $248 million, compared to $267 million for the same period last year.
  • Free Cash Flow for the first nine months of 2025 was $29 million compared to $171 million for the same period of 2024. Free Cash Flow is a non-GAAP financial measure. See the Company’s definition of Free Cash Flow, the explanation as to why it is used, and the reconciliation to net cash provided by operating activities later in this release.
  • Dividends paid during the nine months ended September 28, 2025 increased to $156 million compared to $152 million in the same period of the prior year.

Guidance(1)         

Full-Year 2025

  • Adjusted EPS(2) : Adjusted to $5.65 to $5.75 per diluted share from previous guidance of approximately $6.00
  • Adjusted EBITDA(2): $1,300 million to $1,350 million, substantially in line with previous guidance
  • Cash flow from operating activities: Adjusted to $700 million to $750 million from previous guidance of $800 million

Commenting on the Company’s outlook, Sonoco’s Joachimczyk said, “We are adjusting full-year earnings guidance in anticipation of continuing volume weakness in the fourth quarter especially from our Metal Packaging and Industrial EMEA businesses due to continuing difficult macroeconomic conditions. To address these shortfalls, we are implementing targeted restructuring activities for operations and supporting functions to enable our businesses to better leverage our market capabilities and generate strong cash flow.”

Coker concluded, “Looking ahead at the remainder of the year, our top priorities are to continue building momentum for growth and improving our competitive position by further reducing our cost structure. We believe both our Consumer and Industrial businesses have solid growth funnels with new product and market launches planned in 2026 and beyond. While we are disappointed that our projected 2025 results fall below our previous expectations, we believe Sonoco is in the best position in our history and we are excited about the market opportunity ahead of us to create long-term shareholder value with our focused, operating vision.”

(1)Sonoco’s 2025 guidance includes actual first quarter results from the TFP business. Guidance excludes any impact from the planned divestiture of ThermoSafe in the fourth quarter. Although the Company believes the assumptions reflected in the range of guidance are reasonable, given the uncertainty regarding the future performance of the overall economy, the effects of tariffs, trade policy and inflation, the challenges in global supply chains, potential changes in raw material prices, other costs, and the Company’s effective tax rate, as well as other risks and uncertainties, including those described below, actual results could vary substantially. Further information can be found in the section entitled “Forward-looking Statements” in this release.

(2) Full year 2025 GAAP guidance is not provided in this release due to the likely occurrence of one or more of the following, the timing and magnitude of which we are unable to reliably forecast without unreasonable efforts: restructuring costs and restructuring-related impairment charges, acquisition/divestiture-related costs, gains or losses from the sale of businesses and the income tax effects of these items and/or other income tax-related events. These items could have a significant impact on the Company’s future GAAP financial results. Accordingly, quantitative reconciliations of Adjusted EPS and Adjusted EBITDA guidance and net debt/Adjusted EBITDA targets to the nearest comparable GAAP measures have been omitted in reliance on the exception provided by Item 10 of Regulation S-K.        

Investor Conference Call Webcast
The Company will host a conference call to discuss the third quarter 2025 results. A live audio webcast of the call along with supporting materials will be available on the Sonoco Investor Relations website at https://investor.sonoco.com/. A webcast replay will be available on the Company’s website for at least 30 days following the call.

   
Time: Thursday, October 23, 2025, at 8:00 a.m. Eastern Time
Thursday, October 23, 2025, at 8:00 a.m. Eastern Time
   
Audience
Dial-In:
To listen via telephone, please register in advance at
https://registrations.events/direct/Q4I122820

After registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call.
   
Webcast Link: https://events.q4inc.com/attendee/279947774
   

Contact Information:
Roger Schrum
Head of Investor Relations and Communications
roger.schrum@sonoco.com 
843-339-6018


About Sonoco

Sonoco (NYSE: SON) is a global leader in high-value sustainable metal and fiber consumer and industrial packaging. The Company is a multi-billion-dollar enterprise with approximately 23,400 employees working in 285 operations in 40 countries, serving some of the world’s best-known brands. Guided by our purpose of Better Packaging. Better Life., we strive to foster a culture of innovation, collaboration and excellence to provide solutions that better serve all our stakeholders and support a more sustainable future. Sonoco was proudly named one of America’s Most Trustworthy and Responsible Companies by Newsweek in 2025. For more information on the Company, visit our website at www.sonoco.com.

Forward-looking Statements
Statements included herein that are not historical in nature, are intended to be, and are hereby identified as “forward-looking statements” for purposes of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. In addition, the Company and its representatives may from time to time make other oral or written statements that are also “forward-looking statements.” Words such as “achieve,” “anticipate,” “assume,” “believe,” “can,” “consider,” “commit,” “continue,” “could,” “develop,” “estimate,” “expect,” “forecast,” “focus,” “future,” “goal,” “guidance,” “intend,” “is designed to,” “likely,” “maintain,” “may,” “might,” “objective,” “ongoing,” “opportunity,” “outlook,” “persist,” “plan,” “position,” “possible,” “potential,” “predict,” “project,” “remain,” “seek,” “should,” “strategy,” “target,” “will,” “would,” or the negative thereof, and similar expressions identify forward-looking statements.

Forward-looking statements in this communication include statements regarding, but not limited to: the Company’s future operating and financial performance, including full year 2025 outlook and the anticipated drivers thereof, capital spending in 2025, and cash flow in the fourth quarter of 2025; the pending divestiture of the Company’s ThermoSafe business unit, including the amount of proceeds and the timing thereof; the use of divestiture proceeds to repay debt, and the projected impact thereof on the Company’s net leverage; expectations regarding the need for working capital; the Company’s ability to improve its competitive position and manage costs, including with respect to restructuring of operations and supporting functions; expected growth from planned new product and market launches in 2026 and beyond; opportunities for streamlining the Company’s manufacturing operations to better support its customers; price/cost, customer demand and volume outlook; the effectiveness of and expected benefits from the Company’s strategy and strategic initiatives, including with respect to portfolio simplification and capital allocation priorities; the effects of the changing macroeconomic environment, including trade policies and tariffs, market conditions and interest costs on the Company, its supply chain and its customers, and the Company’s ability to manage risks related thereto; and the Company’s ability to generate long-term shareholder value and return capital to shareholders.

Such forward-looking statements are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management. Such information includes, without limitation, discussions as to guidance and other estimates, perceived opportunities, expectations, beliefs, plans, strategies, goals and objectives concerning our future financial and operating performance. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict.

Therefore, actual results may differ materially from those expressed or forecasted in such forward-looking statements.

Such risks, uncertainties and assumptions include, without limitation, those related to: the Company’s ability to execute on its strategy, including with respect to the integration of the Eviosys operations, divestitures, including the pending divestiture of the Company’s ThermoSafe business unit, cost management, productivity improvements, restructuring and capital expenditures, and achieve the benefits it expects therefrom; conditions in the credit markets; the ability to retain key employees and successfully integrate Eviosys; the ability to realize estimated cost savings, synergies or other anticipated benefits of the Eviosys acquisition, or that such benefits may take longer to realize than expected; diversion of management’s attention; the potential impact of the consummation of the Eviosys acquisition on relationships with clients and other third parties; the operation of new manufacturing capabilities; the Company’s ability to achieve anticipated cost and energy savings; the availability, transportation and pricing of raw materials, energy and transportation, including the impact of changes in tariff or other trade policies or sanctions and escalating trade wars, and the impact of war, general regional instability and other geopolitical tensions (such as the ongoing conflict between Russia and Ukraine, as well as the economic sanctions related thereto, and uncertainty in the Middle East), and the Company’s ability to continue to pass raw material, energy and transportation price increases and surcharges through to customers or otherwise manage these commodity pricing risks; the costs of labor; the effects of inflation, changes related to tariffs or other trade policies and global regulations, as well as the overall uncertainty surrounding international trade relations; fluctuations in consumer demand, volume softness, and other macroeconomic factors on the Company and the industries in which it operates and that it serves; the impact of changing laws and regulations, including the One Big Beautiful Bill Act in the United States, on the Company; the Company’s ability to meet its environmental, sustainability and similar goals and other social and governance goals, including challenges in implementation thereof; and the other risks, uncertainties and assumptions discussed in the Company’s filings with the Securities and Exchange Commission, including its most recent reports on Forms 10-K and 10-Q, particularly under the heading “Risk Factors.” The Company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed herein might not occur.

References to our Website Address

References to our website address and domain names throughout this release are for informational purposes only, or to fulfill specific disclosure requirements of the Securities and Exchange Commission’s rules or the New York Stock Exchange Listing Standards. These references are not intended to, and do not, incorporate the contents of our website by reference into this release.


 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(Dollars and shares in thousands except per share data)
           
  Three Months Ended   Nine Months Ended
  September 28, 2025   September 29, 2024   September 28, 2025   September 29, 2024
Net sales $ 2,131,108     $ 1,354,652     $ 5,750,777     $ 3,942,089  
Cost of sales   1,663,757       1,054,800       4,523,462       3,085,829  
Gross profit   467,351       299,852       1,227,315       856,260  
Selling, general, and administrative expenses   220,966       159,825       648,804       503,355  
Restructuring/Asset impairment charges   48,388       6,149       71,721       55,122  
Loss on divestiture of business   (3,031 )     (31,770 )     (9,297 )     (27,292 )
Operating profit   194,966       102,108       497,493       270,491  
Non-operating pension costs   3,054       2,947       9,157       10,412  
Interest expense   61,243       60,643       181,637       119,481  
Interest income   4,634       5,585       16,104       11,777  
Other (expense)/income, net   (7,541 )           (20,617 )     5,867  
Income from continuing operations before income taxes   127,762       44,103       302,186       158,242  
Provision for income taxes   7,717       15,519       68,364       40,146  
Income before equity in earnings of affiliates   120,045       28,584       233,822       118,096  
Equity in earnings of affiliates, net of tax   3,020       2,807       7,211       6,218  
Net income from continuing operations   123,065       31,391       241,033       124,314  
Net income from discontinued operations         19,818       429,720       83,119  
Net income   123,065       51,209       670,753       207,433  
Net (income)/loss from continuing operations attributable to noncontrolling interests   (147 )     (241 )     17       (399 )
Net income from discontinued operations attributable to noncontrolling interests         (47 )           (125 )
Net income attributable to Sonoco $ 122,918     $ 50,921     $ 670,770     $ 206,909  
               
Weighted average common shares outstanding – diluted   99,648       99,267       99,519       99,221  
               
Diluted earnings from continuing operations per common share $ 1.23     $ 0.31     $ 2.42     $ 1.25  
Diluted earnings from discontinued operations per common share         0.20       4.32       0.84  
Diluted earnings attributable to Sonoco per common share $ 1.23     $ 0.51     $ 6.74     $ 2.09  
Dividends per common share $ 0.53     $ 0.52     $ 1.58     $ 1.55  


 
CONDENSED STATEMENTS OF INCOME FOR DISCONTINUED OPERATIONS (Unaudited)
(Dollars and shares in thousands except per share data)
             
  Three Months Ended   Nine Months Ended
  September 28, 2025   September 29, 2024   September 28, 2025   September 29, 2024
                   
Net sales $     $ 321,213     $ 320,678     $ 994,798  
Cost of sales         262,328       250,854       797,414  
Gross profit         58,885       69,824       197,384  
Selling, general, and administrative expenses         30,821       31,607       82,983  
Restructuring/Asset impairment charges         2,041       426       3,936  
Gain on divestiture of business               625,773        
Operating profit         26,023       663,564       110,465  
Other income, net               182        
Interest expense         1,000       24,911       3,023  
Interest income         430       281       1,352  
Income from discontinued operations before income taxes         25,453       638,752       108,794  
Provision for income taxes         5,635       209,032       25,675  
Net income from discontinued operations         19,818       429,720       83,119  
Net income from discontinued operations attributable to noncontrolling interests         (47 )           (125 )
Net income attributable to discontinued operations $     $ 19,771     $ 429,720     $ 82,994  
Weighted average common shares outstanding – diluted   99,648       99,267       99,519       99,221  
Diluted earnings from discontinued operations per common share $     $ 0.20     $ 4.32     $ 0.84  


 
FINANCIAL SEGMENT INFORMATION (Unaudited)
(Dollars in thousands)
     
    Three Months Ended   Nine Months Ended
    September 28, 2025   September 29, 2024   September 28, 2025   September 29, 2024
Net sales:              
  Consumer Packaging $ 1,438,246     $ 662,297     $ 3,731,872     $ 1,827,018  
  Industrial Paper Packaging   584,969       585,082       1,730,917       1,778,912  
  Total reportable segments   2,023,215       1,247,379       5,462,789       3,605,930  
  All Other   107,893       107,273       287,988       336,159  
  Net sales $ 2,131,108     $ 1,354,652     $ 5,750,777     $ 3,942,089  
                 
               
Operating profit:              
  Consumer Packaging $ 208,985     $ 96,295     $ 510,109     $ 228,618  
  Industrial Paper Packaging   89,857       70,206       242,212       203,008  
  Segment operating profit   298,842       166,501       752,321       431,626  
  All Other   18,302       17,440       43,337       48,430  
  Corporate              
  Restructuring/Asset impairment charges   (48,388 )     (6,149 )     (71,721 )     (55,122 )
  Amortization of acquisition intangibles   (49,034 )     (17,624 )     (135,188 )     (52,997 )
  Loss on divestiture of business   (3,031 )     (31,770 )     (9,297 )     (27,292 )
  Acquisition, integration, and divestiture-related costs   (9,318 )     (15,605 )     (47,745 )     (43,201 )
  Other corporate costs   (8,804 )     (10,368 )     (27,657 )     (34,091 )
  Other operating (charges)/income, net   (3,603 )     (317 )     (6,557 )     3,138  
  Operating profit $ 194,966     $ 102,108     $ 497,493     $ 270,491  


 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(Dollars in thousands)
   
  Nine Months Ended
  September 28, 2025   September 29, 2024
       
Net income $ 670,753     $ 207,433  
Net (gain)/loss on asset impairments, disposition of assets and divestiture of business   (601,304 )     43,946  
Depreciation and amortization   382,623       270,691  
Pension and postretirement plan contributions, net of non-cash expense   (3,589 )     (1,612 )
Changes in working capital   (299,650 )     (115,825 )
Changes in tax accounts   127,412       6,165  
Other operating activity   651       26,840  
Net cash provided by operating activities   276,896       437,638  
       
Purchases of property, plant and equipment, net   (248,251 )     (266,817 )
Proceeds from the sale of business, net   1,814,899       81,212  
Cost of acquisitions, net of cash acquired*   16,528       (3,743 )
Net debt (repayments)/proceeds   (1,938,409 )     1,695,093  
Cash dividends   (155,767 )     (152,397 )
Payments for share repurchases   (10,580 )     (9,172 )
Other inflow/(outflow), including effects of exchange rates on cash   47,490       (3,118 )
Net (decrease)/increase in cash and cash equivalents   (197,194 )     1,778,696  
Cash and cash equivalents at beginning of period   443,060       151,937  
Cash and cash equivalents at end of period $ 245,866     $ 1,930,633  
 
*During 2025, the Company received $16,528 in a final net working capital settlement related to the acquisition of Eviosys.


 
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(Dollars in thousands)
      September 28, 2025   December 31, 2024
Assets      
Current Assets:      
  Cash and cash equivalents $ 244,855   $ 431,010
  Trade accounts receivable, net of allowances   1,092,445     907,526
  Other receivables   199,759     175,877
  Inventories   1,160,029     1,016,139
  Prepaid expenses   136,939     197,134
  Assets held for sale   322,352    
  Current assets of discontinued operations       450,874
    Total Current Assets   3,156,379     3,178,560
Property, plant and equipment, net   2,785,742     2,718,747
Goodwill   2,473,367     2,525,657
Other intangible assets, net   2,721,123     2,586,698
Right of use asset-operating leases   288,491     307,688
Deferred income taxes and other assets   291,022     226,130
Noncurrent assets of discontinued operations       964,310
    Total Assets $ 11,716,124   $ 12,507,790
Liabilities and Equity      
Current Liabilities:      
  Payable to suppliers, accrued expenses and other payables $ 1,820,528   $ 1,734,955
  Notes payable and current portion of long-term debt   1,368,899     2,054,525
  Accrued taxes   165,089     6,755
  Liabilities held for sale   65,387    
  Current liabilities of discontinued operations       242,056
    Total Current Liabilities   3,419,903     4,038,291
Long-term debt, net of current portion   3,787,680     4,985,496
Noncurrent operating lease liabilities   244,789     258,735
Pension and other postretirement benefits   182,546     180,827
Deferred income taxes and other liabilities   761,690     644,317
Noncurrent liabilities of discontinued operations       113,911
    Total Liabilities   8,396,608     10,221,577
    Total Equity   3,319,516     2,286,213
    Total Liabilities and Equity $ 11,716,124   $ 12,507,790


NON-GAAP FINANCIAL MEASURES

The Company’s results, determined in accordance with U.S. generally accepted accounting principles, are referred to as “as reported” or “GAAP” results. The Company uses certain financial performance measures, both internally and externally, that are not in conformity with GAAP (referred to as “non-GAAP financial measures”) to assess and communicate the financial performance of the Company. These non-GAAP financial measures, which are identified using the term “adjusted” (for example, “adjusted operating profit,” “adjusted net income attributable to Sonoco,” and “adjusted diluted EPS”), reflect adjustments to the Company’s GAAP operating results to exclude amounts, including the associated tax effects where applicable, relating to:

  • restructuring/asset impairment charges1;
  • acquisition, integration and divestiture-related costs;
  • gains or losses from the divestiture of businesses;
  • losses from the early extinguishment of debt;
  • non-operating pension costs;
  • amortization expense on acquisition intangibles;
  • changes in last-in, first-out (“LIFO”) inventory reserves;
  • certain income tax events and adjustments;
  • derivative gains/losses;
  • other non-operating income and losses; and
  • certain other items, if any.

1Restructuring and restructuring-related asset impairment charges are a recurring item as the Company’s restructuring programs usually require several years to fully implement, and the Company is continually seeking to take actions that could enhance its efficiency. Although recurring, these charges are subject to significant fluctuations from period to period due to the varying levels of restructuring activity, the inherent imprecision in the estimates used to recognize the impairment of assets, and the wide variety of costs and taxes associated with severance and termination benefits in the countries in which the restructuring actions occur.

The Company’s management believes the exclusion of the amounts related to the above-listed items improves the period-to-period comparability and analysis of the underlying financial performance of the business.

In addition to the “adjusted” results described above, the Company also uses Adjusted EBITDA, Segment Adjusted EBITDA, Segment Adjusted EBITDA Margin, Net Debt and Net Leverage. Adjusted EBITDA is defined as net income excluding the following: interest expense; interest income; provision for income taxes; depreciation and amortization expense; non-operating pension costs; net income/loss attributable to noncontrolling interests; restructuring/asset impairment charges; changes in LIFO inventory reserves; gains/losses from the divestiture of businesses; acquisition, integration and divestiture-related costs; other income; derivative gains/losses; and other non-GAAP adjustments, if any, that may arise from time to time. Segment Adjusted EBITDA is defined as segment operating profit plus depreciation and amortization expense and equity in earnings of affiliates, net of tax. Segment Adjusted EBITDA Margin is defined as Segment Adjusted EBITDA divided by segment net sales. Net Debt is defined as the total of the Company’s short and long-term debt less cash and cash equivalents.

Segment Adjusted EBITDA is reconciled to the closest GAAP measure of segment profitability, segment operating profit as the Company does not calculate net income by segment. Segment operating profit is the measure of segment profit or loss reported to the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing their performance in accordance with Accounting Standards Codification 280 - “Segment Reporting,” as prescribed by the Financial Accounting Standards Board.

Segment results, which are reviewed by the Company’s management to evaluate segment performance, do not include the following: restructuring/asset impairment charges; amortization of acquisition intangibles; acquisition, integration and divestiture-related costs; changes in LIFO inventory reserves; gains/losses from the sale of businesses; gains/losses from derivatives; or certain other items, if any, the exclusion of which the Company believes improves the comparability and analysis of the ongoing operating performance of the business. Accordingly, the term “segment operating profit” is defined as the segment’s portion of “operating profit” excluding those items. All other general corporate expenses have been allocated as operating costs to each of the Company’s reportable segments and the All Other group of businesses, except for costs related to discontinued operations.

The Company’s non-GAAP financial measures are not calculated in accordance with, nor are they an alternative for, measures conforming to GAAP, and they may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles.

The Company presents these non-GAAP financial measures to provide investors with information to evaluate Sonoco’s operating results in a manner similar to how management evaluates business performance. The Company consistently applies its non-GAAP financial measures presented herein and uses them for internal planning and forecasting purposes, to evaluate its ongoing operations, and to evaluate the ultimate performance of management and each business unit against plans/forecasts. In addition, these same non-GAAP financial measures are used in determining incentive compensation for the entire management team and in providing earnings guidance to the investing community.

Material limitations associated with the use of such measures include that they do not reflect all period costs included in operating expenses and may not be comparable with similarly named financial measures of other companies. Furthermore, the calculations of these non-GAAP financial measures are based on subjective determinations of management regarding the nature and classification of events and circumstances that the investor may find material and view differently.

To compensate for any limitations in such non-GAAP financial measures, management believes that it is useful in evaluating the Company’s results to review both GAAP information, which includes all of the items impacting financial results, and the related non-GAAP financial measures that exclude certain elements, as described above. Further, Sonoco management does not, nor does it suggest that investors should, consider any non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever reviewing a non-GAAP financial measure, investors are encouraged to review and consider the related reconciliation to understand how it differs from the most directly comparable GAAP measure.

Free Cash Flow

The Company uses the non-GAAP financial measure of “Free Cash Flow,” which it defines as cash flow from operations minus net capital expenditures. Net capital expenditures are defined as capital expenditures minus proceeds from the disposition of capital assets. Free Cash Flow may not represent the amount of cash flow available for general discretionary use because it excludes non-discretionary expenditures, such as mandatory debt repayments and required settlements of recorded and/or contingent liabilities not reflected in cash flow from operations.

QUARTERLY RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES

The following tables reconcile the Company’s non-GAAP financial measures to their most directly comparable GAAP financial measures in the Company’s Condensed Consolidated Statements of Income for the three-month periods ended September 28, 2025 and September 29, 2024.

Adjusted Operating Profit, Adjusted Income from Continuing Operations Before Income Taxes, Adjusted Provision for Income Taxes, Adjusted Net Income Attributable to Sonoco, and Adjusted Diluted EPS

  For the three-month period ended September 28, 2025
Dollars in thousands, except per share data Operating Profit
Income from Continuing Operations Before Income Taxes
Provision for Income Taxes Net Income Attributable to Sonoco Diluted EPS
As Reported (GAAP) $ 194,966   $ 127,762   $ 7,717   $ 122,918   $ 1.23  
Acquisition, integration and divestiture-related costs1   9,318     9,318     2,377     6,941     0.07  
Amortization of acquisition intangibles   49,034     49,034     10,581     38,453     0.39  
Restructuring/Asset impairment charges   48,388     48,388     11,117     37,221     0.37  
Loss/(Gain) on divestiture of business2   3,031     3,031     27,569     (24,538 )   (0.25 )
Non-operating pension costs       3,054     631     2,423     0.02  
Net losses from derivatives   2,035     2,035     502     1,533     0.02  
Other adjustments3   1,568     1,568     (4,652 )   6,220     0.07  
Total adjustments   113,374     116,428     48,125     68,253     0.69  
Adjusted $ 308,340   $ 244,190   $ 55,842   $ 191,171   $ 1.92  
Due to rounding, individual items may not sum appropriately.        

1 Acquisition, integration and divestiture-related costs relate primarily to the Company’s December 2024 acquisition of Eviosys and April 2025 divestiture of TFP.
2 Loss/(Gain) on divestiture of business includes the recognition of a deferred tax benefit on the outside basis difference related to the ThermoSafe business being classified as held for sale.
3 Other adjustments include an adjustment to deferred taxes from post-acquisition restructuring of the partitions business, provision-to-return adjustments related to the divested TFP business, and an increase in the valuation allowance on foreign tax credits.

   
  For the three-month period ended September 29, 2024
Dollars in thousands, except per share data Operating Profit Income from Continuing Operations Before Income Taxes Provision for Income Taxes Net Income Attributable to Sonoco Diluted EPS
As Reported (GAAP)1 $ 102,108   $ 44,103   $ 15,519   $ 50,921   $ 0.51  
Acquisition, integration and divestiture-related costs2   15,605     45,786     5,595     43,292     0.44  
Changes in LIFO inventory reserves   790     790     199     591     0.01  
Amortization of acquisition intangibles   17,624     17,624     4,402     17,082     0.17  
Restructuring/Asset impairment charges   6,149     6,149     1,097     6,560     0.07  
Loss on divestiture of business   31,770     31,770     454     31,316     0.31  
Non-operating pension costs       2,947     738     2,209     0.02  
Net gains from derivatives   (210 )   (210 )   (53 )   (157 )    
Other adjustments   (263 )   (685 )   3,324     (3,928 )   (0.04 )
Total adjustments   71,465     104,171     15,756     96,965     0.98  
Adjusted $ 173,573   $ 148,274   $ 31,275   $ 147,886   $ 1.49  
Due to rounding, individual items may not sum appropriately.      

1 Operating profit, income from continuing operations before income taxes, and provision for income taxes exclude results related to discontinued operations of $26,023, $25,453 and $5,635, respectively.
2 Acquisition, integration and divestiture-related costs include losses on treasury lock derivative instruments and amortization of financing fees totaling $30,181 related to debt instruments associated with the financing of the Eviosys acquisition. These amortization costs are included in “Interest expense” in the Company’s Condensed Consolidated Statements of Income.

     
Adjusted EBITDA1    
  Three Months Ended
Dollars in thousands September 28, 2025 September 29, 2024
     
Net income attributable to Sonoco $ 122,918   $ 50,921  
Adjustments:    
Interest expense   61,243     61,643  
Interest income   (4,634 )   (6,014 )
Provision for income taxes   7,717     21,154  
Depreciation and amortization   131,656     90,646  
Non-operating pension costs   3,054     2,947  
Net income attributable to noncontrolling interests   147     288  
Restructuring/Asset impairment charges   48,388     8,190  
Changes in LIFO inventory reserves       790  
Loss on divestiture of business   3,031     31,770  
Acquisition, integration and divestiture-related costs   9,318     19,623  
Net loss/(gain) from derivatives   2,035     (210 )
Other non-GAAP adjustments   1,568     (273 )
Adjusted EBITDA $ 386,441   $ 281,475  

1Adjusted EBITDA is calculated on a total Company basis, including both continuing operations and discontinued operations.

 
Segment and All Other Adjusted EBITDA and Adjusted EBITDA Margin Reconciliation
For the Three Months Ended September 28, 2025        
Excludes results of discontinued operations          
Dollars in thousands Consumer Industrial All Other Corporate Total
Segment and Total Operating Profit $ 208,985   $ 89,857   $ 18,302   $ (122,178 ) $ 194,966  
Adjustments:          
Depreciation and amortization1   50,419     29,955     2,248     49,034     131,656  
Other expense2               (7,541 )   (7,541 )
Equity in earnings of affiliates, net of tax   190     2,830             3,020  
Restructuring/Asset impairment charges3               48,388     48,388  
Acquisition, integration and divestiture-related costs4               9,318     9,318  
Loss on divestiture of business5               3,031     3,031  
Net loss from derivatives6               2,035     2,035  
Other non-GAAP adjustments               1,568     1,568  
Segment Adjusted EBITDA $ 259,594   $ 122,642   $ 20,550   $ (16,345 ) $ 386,441  
           
Net Sales $ 1,438,246   $ 584,969   $ 107,893      
Segment Operating Profit Margin   14.5 %   15.4 %   17.0 %    
Segment Adjusted EBITDA Margin   18.0 %   21.0 %   19.0 %    

1Included in Corporate is the amortization of acquisition intangibles associated with the Consumer segment of $43,397, the Industrial segment of $5,485, and the All Other group of businesses of $152.
2These expenses relate to charges from third-party financial institutions related to our centralized treasury program under which the Company sells certain trade accounts receivables in order to accelerate its cash collection cycle primarily within the Consumer segment.
3Included in Corporate are restructuring/asset impairment charges associated with the Consumer segment of $35,027, and the Industrial segment of $11,181.
4Included in Corporate are acquisition, integration and divestiture-related costs associated with the Consumer segment of $1,293 and the Industrial segment of $97.
5Included in Corporate is a $31 loss on the sale of a recycling facility in Asheville, North Carolina associated with the Industrial segment and a $3,000 charge related to the pending divestiture of ThermoSafe, part of the All Other group of businesses.
6Included in Corporate are net losses from derivatives associated with the Consumer segment of $196, the Industrial segment of $1,760, and the All Other group of businesses of $79.

 
Segment and All Other Adjusted EBITDA and Adjusted EBITDA Margin Reconciliation
For the Three Months Ended September 29, 2024
Excludes results of discontinued operations          
Dollars in thousands Consumer Industrial All Other Corporate Total
Segment and Total Operating Profit $ 96,295   $ 70,206   $ 17,440   $ (81,833 ) $ 102,108  
Adjustments:          
Depreciation and amortization1   25,576     28,989     2,729     17,624     74,918  
Equity in earnings of affiliates, net of tax   369     2,438             2,807  
Restructuring/Asset impairment charges2               6,149     6,149  
Changes in LIFO inventory reserves3               790     790  
Acquisition, integration and divestiture-related costs4               15,605     15,605  
Loss on divestiture of business5               31,770     31,770  
Net gains from derivatives6               (210 )   (210 )
Other non-GAAP adjustments               (263 )   (263 )
Segment Adjusted EBITDA $ 122,240   $ 101,633   $ 20,169   $ (10,368 ) $ 233,674  
           
Net Sales $ 662,297   $ 585,082   $ 107,273      
Segment Operating Profit Margin   14.5 %   12.0 %   16.3 %    
Segment Adjusted EBITDA Margin   18.5 %   17.4 %   18.8 %    

1Included in Corporate is the amortization of acquisition intangibles associated with the Consumer segment of $11,110, the Industrial segment of $6,306, and the All Other group of businesses of $208.
2Included in Corporate are restructuring/asset impairment charges associated with the Consumer segment of $2,468 and the Industrial segment of $3,798.
3Included in Corporate are changes in LIFO inventory reserves associated with the Consumer segment of $758 and the Industrial segment of $32.
4Included in Corporate are acquisition, integration and divestiture-related costs associated with the Industrial segment of $4,529 and the Consumer segment of $(137).
5Included in Corporate are losses from the divestiture of business associated with the Industrial segment of $29,965 related to the sale of two production facilities in China and the All Other group of businesses of $1,805 related to the sale of the Protective Solutions business (“Protexic”).
6Included in Corporate are net gains from derivatives associated with the Consumer segment of $(41), the Industrial segment of $(160), and the All Other group of businesses of $(9).


YEAR-TO-DATE RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES

The following tables reconcile the Company’s non-GAAP financial measures to their most directly comparable GAAP financial measures in the Company’s Condensed Consolidated Statements of Income for the nine-month periods ended September 28, 2025 and September 29, 2024.

Adjusted Operating Profit, Adjusted Income from Continuing Operations Before Income Taxes, Adjusted Provision for Income Taxes, Adjusted Net Income Attributable to Sonoco, and Adjusted Diluted EPS

  For the nine-month period ended September 28, 2025
Dollars in thousands, except per share data Operating Profit Income from Continuing Operations Before Income Taxes Provision for Income Taxes Net Income Attributable to Sonoco Diluted EPS
As Reported (GAAP)1 $ 497,493 $ 302,186 $ 68,364   $ 670,770   $ 6.74  
Acquisition, integration and divestiture-related costs2   47,745   47,745   11,134     46,277     0.47  
Changes in LIFO inventory reserves   1,755   1,755   433     1,322     0.01  
Amortization of acquisition intangibles   135,188   135,188   29,586     105,389     1.06  
Restructuring/Asset impairment charges   71,721   71,721   16,514     55,109     0.55  
Loss/(Gain) on divestiture of business3   9,297   9,297   28,455     (443,706 )   (4.46 )
Non-operating pension costs     9,157   2,190     6,967     0.07  
Net losses from derivatives   1,240   1,240   306     934     0.01  
Other adjustments4   3,562   3,562   (14,456 )   21,064     0.21  
Total adjustments   270,508   279,665   74,162     (206,644 )   (2.08 )
Adjusted $ 768,001 $ 581,851 $ 142,526   $ 464,126   $ 4.66  
Due to rounding, individual items may not sum appropriately.      

1 Operating profit, income from continuing operations before income taxes, and provision for income taxes exclude results related to discontinued operations of $663,564, $638,752, and $209,032, respectively.
2 Acquisition, integration and divestiture-related costs relate primarily to the Company’s December 2024 acquisition of Eviosys and the April 2025 divestiture of TFP.
3 Loss/(Gain) on divestiture of business primarily consists of the gain on the sale of TFP, included in “Net income from discontinued operations” in the Company’s Condensed Consolidated Statements of Income, and the recognition of a deferred tax benefit on the outside basis difference related to the ThermoSafe business being classified as held for sale.
4 Other adjustments include discrete tax items primarily related to tax rate changes, an adjustment to deferred taxes from post-acquisition restructuring of the partitions business, provision-to-return adjustments related to the divested TFP business, and an increase in the valuation allowance on foreign tax credits.

   
  For the nine-month period ended September 29, 2024
Dollars in thousands, except per share data Operating Profit Income from Continuing Operations Before Income Taxes Provision for Income Taxes Net Income Attributable to Sonoco Diluted EPS
As Reported (GAAP)1 $ 270,491   $ 158,242   $ 40,146   $ 206,909   $ 2.09  
Acquisition, integration and divestiture-related costs2   43,201     73,382     12,659     64,064     0.64  
Changes in LIFO inventory reserves   (197 )   (197 )   (49 )   (148 )    
Amortization of acquisition intangibles   52,997     52,997     13,105     51,423     0.52  
Restructuring/Asset impairment charges   55,122     55,122     10,938     47,260     0.48  
Loss on divestiture of business   27,292     27,292     1,676     25,616     0.26  
Other income, net       (5,867 )       (5,867 )   (0.06 )
Non-operating pension costs       10,412     2,593     7,819     0.08  
Net gains from derivatives   (3,981 )   (3,981 )   (1,001 )   (2,980 )   (0.03 )
Other adjustments3   1,040     1,040     8,959     (7,961 )   (0.09 )
Total adjustments   175,474     210,200     48,880     179,226     1.80  
Adjusted $ 445,965   $ 368,442   $ 89,026   $ 386,135   $ 3.89  
Due to rounding, individual items may not sum appropriately.      

1 Operating profit, income from continuing operations before income taxes, and provision for income taxes exclude results related to discontinued operations of $110,465, $108,794, and $25,675, respectively.
2 Acquisition, integration and divestiture-related costs include losses on treasury lock derivative instruments and amortization of financing fees totaling $30,181 related to debt instruments associated with the financing of the Eviosys acquisition. These amortization costs are included in “Interest expense” in the Company’s Condensed Consolidated Statements of Income.
3 Other adjustments include discrete tax items primarily related to a $10,070 adjustment to deferred taxes from the post-acquisition restructuring of the partitions business.

     
Adjusted EBITDA1    
  Nine Months Ended
Dollars in thousands September 28, 2025 September 29, 2024
     
Net income attributable to Sonoco $ 670,770   $ 206,909  
Adjustments:    
Interest expense   206,548     122,503  
Interest income   (16,385 )   (13,127 )
Provision for income taxes   277,396     65,821  
Depreciation and amortization   382,623     270,691  
Non-operating pension costs   9,157     10,412  
Net (loss)/income attributable to noncontrolling interests   (17 )   524  
Restructuring/Asset impairment charges   72,147     59,058  
Changes in LIFO inventory reserves   1,755     (197 )
(Gain)/Loss on divestiture of business   (616,476 )   27,292  
Acquisition, integration and divestiture-related costs   60,421     47,553  
Other income, net       (5,867 )
Net loss/(gain) from derivatives   1,240     (3,981 )
Other non-GAAP adjustments   2,949     851  
Adjusted EBITDA $ 1,052,128   $ 788,442  
     
Net Sales $ 5,750,777   $ 3,942,089  
Net sales related to discontinued operations $ 320,678   $ 994,798  

1Adjusted EBITDA is calculated on a total Company basis, including both continuing and discontinued operations.


The following tables reconcile segment operating profit, the closest GAAP measure of profitability, to segment adjusted EBITDA.

Segment and All Other Adjusted EBITDA and Adjusted EBITDA Margin Reconciliation
For the Nine Months Ended September 28, 2025
Excludes results of discontinued operations
Dollars in thousands Consumer Industrial All Other Corporate Total
Segment and Total Operating Profit $ 510,109   $ 242,212   $ 43,337   $ (298,165 ) $ 497,493  
Adjustments:          
Depreciation and amortization1   152,175     88,126     7,445     135,188     382,934  
Other expense2               (20,617 )   (20,617 )
Equity in earnings of affiliates, net of tax   309     6,902             7,211  
Restructuring/Asset impairment charges3               71,721     71,721  
Changes in LIFO inventory reserves4               1,755     1,755  
Acquisition, integration and divestiture-related costs5               47,745     47,745  
Loss on divestiture of business6               9,297     9,297  
Net loss from derivatives7               1,240     1,240  
Other non-GAAP adjustments               3,562     3,562  
Segment Adjusted EBITDA $ 662,593   $ 337,240   $ 50,782   $ (48,274 ) $ 1,002,341  
           
Net Sales $ 3,731,872   $ 1,730,917   $ 287,988      
Segment Operating Profit Margin   13.7 %   14.0 %   15.0 %    
Segment Adjusted EBITDA Margin   17.8 %   19.5 %   17.6 %    

1Included in Corporate is the amortization of acquisition intangibles associated with the Consumer segment of $118,232, the Industrial segment of $16,405, and the All Other group of businesses of $551.
2These expenses relate to charges from third-party financial institutions related to our centralized treasury program under which the Company sells certain trade accounts receivables in order to accelerate its cash collection cycle primarily within the Consumer segment.
3Included in Corporate are restructuring/asset impairment charges associated with the Consumer segment of $37,736 and the Industrial segment of $31,944, and income associated with the All Other group of businesses of $(27).
4Included in Corporate are changes in LIFO inventory reserves associated with the Consumer segment of $1,755.
5Included in Corporate are acquisition, integration and divestiture-related costs associated with the Consumer segment of $22,502 and the Industrial segment of $528.
6Included in Corporate are net losses on the divestiture of businesses associated with the Industrial segment of $6,297, including losses of $5,390 related to the sale of the Company’s operations in Venezuela and $2,114 from the sale of a recycling facility in Asheville, North Carolina, partially offset by a gain of $(1,207) from the sale of a production facility in France and a charge associated with the All Other group of businesses of $3,000 related to the pending divestiture of ThermoSafe.
7Included in Corporate are net losses from derivatives associated with the Consumer segment of $120, the Industrial segment of $1,072, and the All Other group of businesses of $48.

 
Segment and All Other Adjusted EBITDA and Adjusted EBITDA Margin Reconciliation
For the Nine Months Ended September 29, 2024
Excludes results of discontinued operations
Dollars in thousands Consumer Industrial All Other Corporate Total
Segment and Total Operating Profit $ 228,618   $ 203,008   $ 48,430   $ (209,565 ) $ 270,491  
Adjustments:          
Depreciation and amortization1   75,705     86,133     9,098     52,997     223,933  
Equity in earnings of affiliates, net of tax   416     5,802             6,218  
Restructuring/Asset impairment charges2               55,122     55,122  
Changes in LIFO inventory reserves3               (197 )   (197 )
Acquisition, integration and divestiture-related costs4               43,201     43,201  
Loss on divestiture of business5               27,292     27,292  
Net gains from derivatives6               (3,981 )   (3,981 )
Other non-GAAP adjustments               1,040     1,040  
Segment Adjusted EBITDA $ 304,739   $ 294,943   $ 57,528   $ (34,091 ) $ 623,119  
           
Net Sales $ 1,827,018   $ 1,778,912   $ 336,159      
Segment Operating Profit Margin   12.5 %   11.4 %   14.4 %    
Segment Adjusted EBITDA Margin   16.7 %   16.6 %   17.1 %    

1Included in Corporate is the amortization of acquisition intangibles associated with the Consumer segment of $33,209, the Industrial segment of $19,168, and the All Other group of businesses of $620.
2Included in Corporate are restructuring/asset impairment charges associated with the Consumer segment of $16,661, the Industrial segment of $34,138, and the All Other group of businesses of $1,362.
3Included in Corporate are changes in LIFO inventory reserves associated with the Consumer segment of $388 and the Industrial segment of $(585).
4Included in Corporate are acquisition, integration and divestiture-related costs associated with the Consumer segment of $144 and the Industrial segment of $3,658.
5Included in Corporate are net losses from the divestiture of businesses within the Industrial segment of $28,715, including a loss of $29,965 from the sale of two production facilities in China, partially offset by a gain of $(1,250) from the sale of the S3 business, and a gain on divestiture of businesses associated with the All Other group of businesses of $(1,423) related to the sale of Protexic.
6Included in Corporate are net gains from derivatives associated with the Consumer segment of $(624), the Industrial segment of $(2,628), and the All Other group of businesses of $(729).


The following table reconciles the GAAP measure “Net cash provided by operating activities” to the non-GAAP measure “Free cash flow.”

  Nine Months Ended
FREE CASH FLOW September 28, 2025   September 29, 2024
       
Net cash provided by operating activities $ 276,896     $ 437,638  
Purchase of property, plant and equipment, net   (248,251 )     (266,817 )
Free Cash Flow $ 28,645     $ 170,821  

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions